The store will not work correctly when cookies are disabled.
5-[(2(S)-Azetidinyl)methoxy]-3-[(N-ethylcarbamoyloxy)-methyl]isoxazole
ID: ALA2165441
PubChem CID: 56949917
Max Phase: Preclinical
Molecular Formula: C11H17N3O4
Molecular Weight: 255.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCNC(=O)OCc1cc(OC[C@@H]2CCN2)on1
Standard InChI: InChI=1S/C11H17N3O4/c1-2-12-11(15)17-7-9-5-10(18-14-9)16-6-8-3-4-13-8/h5,8,13H,2-4,6-7H2,1H3,(H,12,15)/t8-/m0/s1
Standard InChI Key: DGVVOJAYZVNQDK-QMMMGPOBSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
4.4374 -25.3205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2624 -25.3205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5192 -24.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8499 -24.0497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1849 -24.5364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2291 -24.1164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4667 -24.1205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7516 -24.5321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0377 -24.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8205 -23.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0234 -23.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2359 -24.3305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9480 -24.5212 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9568 -25.3461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6757 -25.7509 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2467 -25.7662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6844 -26.5759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4007 -26.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
3 6 1 0
5 7 1 0
7 8 1 0
9 8 1 1
9 10 1 0
10 11 1 0
11 12 1 0
12 9 1 0
6 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
18 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.27 | Molecular Weight (Monoisotopic): 255.1219 | AlogP: 0.66 | #Rotatable Bonds: 6 |
Polar Surface Area: 85.62 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.61 | CX LogP: -0.14 | CX LogD: -2.32 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.78 | Np Likeness Score: -0.75 |
References
1. Yu LF, Tückmantel W, Eaton JB, Caldarone B, Fedolak A, Hanania T, Brunner D, Lukas RJ, Kozikowski AP.. (2012) Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity., 55 (2): [PMID:22148173] [10.1021/jm201301h] |